Rare therapies and UK regulatory considerations Page summary: A paper outlining MHRA’s intentions to make it quicker and easier to get rare disease therapies tested, manufactured and approved in the UK. Change made: First published. Time updated: 7:55am, 2 November 2025 Major change for rare disease treatments on way, signals MHRA Page summary: New paper sets out UK regulator’s intentions…
Ben KempNovember 13, 2025